Demographic data |
Age at cohort entry, yr |
Mean ± SD, yr | 40.18 ± 10.79 | 36.33 ± 9.45 | 38 |
Median (IQR), yr | 42 (31–50) | 36 (28–44) | 42 |
18–25 | 7701 (12.9) | 99 (13.5) | 2 |
26–35 | 13 014 (21.8) | 256 (34.9) | 30 |
36–45 | 14 892 (24.9) | 230 (31.4) | 14 |
46–55 | 24 189 (40.5) | 148 (20.2) | 45 |
Sex, female | 26 324 (44.0) | 390 (53.2) | 18 |
Residential status |
Urban | 51 756 (86.6) | 640 (87.3) | 2 |
Rural | 8011 (13.4) | 93 (12.7) | 2 |
Missing | 29 (0.0) | 0 (0.0) | 3 |
Socioeconomic status |
1 (lowest) | 23 187 (38.8) | 320 (43.7) | 10 |
2 | 12 876 (21.5) | 162 (22.1) | 1 |
3 | 10 365 (17.3) | 113 (15.4) | 5 |
4 | 7531 (12.6) | 77 (10.5) | 7 |
5 (highest) | 5837 (9.8) | 61 (8.3) | 5 |
Comorbidities |
Alcohol abuse | 3658 (6.1) | 15 (2.0) | 21 |
Bipolar disorder | 733 (1.2) | < 6‡ | 7 |
Chronic liver disease | 4220 (7.1) | 22 (3.0) | 19 |
Depression and/or anxiety | 11 770 (19.7) | 120 (16.4) | 9 |
Hepatitis B | 165 (0.3) | 0 (0.0) | 7 |
Hepatitis C | 8609 (14.4) | 135 (18.4) | 11 |
HIV | 2209 (3.7) | 46 (6.3) | 12 |
Schizophrenia | 1065 (1.8) | < 6‡ | 10 |
Self-harm | 8244 (13.8) | 94 (12.8) | 3 |
Medication use |
Antibiotics | 14 544 (24.3) | 223 (30.4) | 14 |
Anticoagulants | 590 (1.0) | 15 (2.0) | 9 |
Antipsychotics | 9239 (15.5) | 94 (12.8) | 8 |
Benzodiazepines | 12 909 (21.6) | 144 (19.6) | 5 |
Lithium | 613 (1.0) | < 6‡ | 7 |
Opioids | 23 006 (38.5) | 366 (49.9) | 23 |
General measures of comorbidity |
No. of unique drug prescriptions filled in 1 year |
Mean ± SD | 4.08 ± 5.59 | 3.85 ± 4.80 | 4 |
Median (IQR) | 1 (0–7) | 2 (0–6) | 7 |
No. of hospital admissions in 1 year |
Mean ± SD | 1.17 ± 2.29 | 1.10 ± 1.95 | 3 |
Median (IQR) | 0 (0–1) | 0 (−1) | 1 |
No. of emergency department visits in 1 year |
Mean ± SD | 4.58 ± 8.43 | 5.01 ± 6.43 | 6 |
Median (IQR) | 2 (1–5) | 3 (1–7) | 29 |
No. of family physician visits in 1 year |
Mean ± SD | 21.05 ± 25.07 | 22.78 ± 24.76 | 7 |
Median (IQR) | 11 (5–27) | 13 (5–33) | 7 |